( September 16, 2014) -- As FTC Chairwoman Edith Ramirez spoke with reporters about the Commission’s recent case against several pharmaceutical firms for allegedly scheming to delay consumers’ access to lower-cost generic versions of the drug AndroGel, she acknowledged that this lawsuit marked a first for the agency....